Labshake search
Citations for R&D Systems :
101 - 150 of 2868 citations for Primary Human Cardiac Fibroblast Cells since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2020Quote: ... 40 ng/ml basic fibroblast growth factor (bfgf, R&D Systems, 233-FB/CF), 1X non-essential amino acids ...
-
bioRxiv - Molecular Biology 2021Quote: ... basic fibroblast growth factor (bFGF, 20 ng/mL, Cat. #4114-TC; R&D Systems), and gentamicin sulfate (50 μg/mL).
-
bioRxiv - Pathology 2021Quote: ... 1% Antibiotic-Antimycotic and 20ng/ml recombinant fibroblast growth factor 2 (R&D Systems)) and passaged using Accutase (Innovative Cell Technologies)19 ...
-
bioRxiv - Immunology 2020Quote: ... Fibroblasts were stimulated with 10 ng/mL TNF-α (210-TA; R&D Systems) and 10 ng/mL IFN-γ (285-IF ...
-
bioRxiv - Biophysics 2022Quote: ... 0.004% (40 ng/mL) basic fibroblast growth factor (R&D Systems, 233-FB/CF), 1× non-essential amino acids ...
-
bioRxiv - Neuroscience 2024Quote: ... and 20 ng ml−1 basic fibroblast growth factor (R&D Systems, 233-FB), with every day medium change for another 8 days ...
-
bioRxiv - Immunology 2021Quote: ... cells were stimulated with human IL-1β (10 ng/mL, R&D Systems) 2 hours before the crosslinking ...
-
bioRxiv - Cancer Biology 2022Quote: ... supplemented with human stem cell factor (SCF, 100 ng/mL, R&D Systems), human interleukin-3 (IL-3 ...
-
bioRxiv - Physiology 2023Quote: ... Cells were stimulated by addition of recombinant human IL-1β (R&D Systems) and/or filter-concentrated JAR cell conditioned media as indicated ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... Cells were aspirated and incubated overnight at 4°C with either: primary goat polyclonal antibody to Human ACE-2 (AF933; R&D Systems; 1:100); primary rabbit monoclonal antibody to TMPRSS2 (ab92323 ...
-
bioRxiv - Molecular Biology 2021Quote: ... the cells were incubated using a primary antibody against NPHS1 (R&D Systems, #AF4269), diluted 1:100 in FACS buffer (PBS supplemented with 1% (v/v ...
-
bioRxiv - Bioengineering 2022Quote: ... was determined using the dot blot-based mouse XL cytokine array kit for the model group breast tissues and human XL cytokine array kit and human XL oncology array kit for the human cell conditioned media following manufacturer’s instructions (R&D Systems, Cat. No: ARY028). Briefly ...
-
bioRxiv - Cancer Biology 2023Quote: Human cell line culture supernatants were analyzed using an R&D systems Human Premixed Multi-Analyte Kit (R&D Systems, Inc., Minneapolis, MN, USA) and a Luminex 200 (RRID ...
-
bioRxiv - Neuroscience 2021Quote: ... and 100 ng/ml murine recombinant fibroblast growth factor 8b (FGF-8b, R&D Systems) for 7 days in vitro (DIV) ...
-
bioRxiv - Bioengineering 2019Quote: ... and 10 ng/ml fibroblast growth factor-2 (FGF-2, R&D Systems, Minneapolis, MN) (39 ...
-
bioRxiv - Neuroscience 2023Quote: ... and 20 ng ml−1 basic fibroblast growth factor (FGF2; R&D Systems, 233-FB) for 16 d ...
-
bioRxiv - Neuroscience 2024Quote: ... and basic fibroblast growth factor (bFGF, 20 ng ml-1, R&D Systems, 233-FB) until day 24 ...
-
bioRxiv - Cell Biology 2020Quote: ... FFPE pancreas sections were incubated overnight at +4°C with primary antibody monoclonal mouse anti-human ACE2 (cat. MAB933, R&D System, Minneapolis, MS, USA) diluted 1:33 in PBS 1X supplemented with 3% BSA and with polyclonal rabbit anti-CD31 (cat ...
-
bioRxiv - Biochemistry 2021Quote: ... cells were resuspended in Goat anti-Human ACE2 antibody (1:500, R&D Systems) in the flow buffer ...
-
bioRxiv - Cancer Biology 2021Quote: ... the cells were treated with recombinant human IFNγ (R&D Systems, 285-IF-100) by adding an equal volume of the complete culture media containing the cytokine ...
-
bioRxiv - Genomics 2019Quote: ... 50 ng/mL carrier-free recombinant human stem cell factor (SCF; R&D Systems), 50 ng/mL TPO (R&D Systems) ...
-
bioRxiv - Developmental Biology 2020Quote: ... cells were treated with 100ng/mL human recombinant FGF4 (R&D Systems, 235-F4) in the presence of 10 μg/mL heparin sulfate and 3 μM BI-D1870 RSK inhibitor at 37°C ...
-
bioRxiv - Immunology 2022Quote: ... cells were immunostained with a goat anti-human ACE2 antibody (#AF933, R&D Systems) followed by immunostaining with a secondary antibody donkey anti-goat Alexa Fluor 488 (#A-11055 ...
-
bioRxiv - Systems Biology 2019Quote: ... cells were incubated with titrated concentrations of human TGF-β1 protein (R&D systems) in the complete culture medium ...
-
bioRxiv - Microbiology 2020Quote: ... cells were then fed with 20ng/ml human BMP4 (R&D Systems, PRD314-10), 0.5µM all-trans retinoic acid (ATRA ...
-
bioRxiv - Developmental Biology 2022Quote: ... the dissociated cells were stained with APC-conjugated anti-human DLK1 (R&D systems). Cells stained with the cell surface marker and those expressing NT were sorted using FACSAria Fusion (BD Biosciences ...
-
bioRxiv - Cancer Biology 2022Quote: ... cells were stimulated with 50 ng/ml recombinant human BMP-9 (R&D Systems) and 150 ng/ml recombinant human VEGF (PeproTech ...
-
ANGPTL8 R59W variant influences inflammation through modulating NF-κB pathway under TNFα stimulationbioRxiv - Biochemistry 2023Quote: ... the cells were treated with Recombinant Human TNFα Protein (R&D Systems, MN, USA) at 25ng/mL for 18 hours ...
-
bioRxiv - Neuroscience 2023Quote: ... Cells were then incubated overnight with human PRL (R&D Systems, 682-PL-050)
-
bioRxiv - Immunology 2023Quote: ... cells were incubated with 10μg/ml human anti-TNFR1 (clone 16805) (R&D System), 20μg/ml human anti-IFNGR1 (clone GIR208 ...
-
bioRxiv - Immunology 2023Quote: ... Cells were incubated with anti-human CCR2-biotin (FAB151B; R&D Systems/ 357224; BioLegend) in FACS buffer (HBSS ...
-
bioRxiv - Immunology 2023Quote: ... The cells were then stained with mouse anti-human CCR1 antibody (2.5 µg/106 cells; mab145, R&D Systems) for 20 min at RT ...
-
bioRxiv - Cancer Biology 2021Quote: ... Cells were incubated with anti-MHC primary antibody (MHC; R&D Systems, Minneapolis, MN, USA) (1:400 ...
-
bioRxiv - Immunology 2022Quote: ... Primary B cell complete media also contains 5 ng/ml of BAFF (R&D Systems).
-
bioRxiv - Genomics 2021Quote: ... Cells were then incubated in primary antibodies (SOX17-R&D Systems, AF1924, SOX2-Millipore, ab5603) diluted at 1:500 in 2% horse serum ...
-
bioRxiv - Microbiology 2023Quote: ... This was followed by incubation of the cut membranes with primary antibody polyclonal goat anti-human EpCAM (R&D Systems, AF960, 1:100 in SEA BLOCK) overnight at 4°C in a humidified chamber ...
-
bioRxiv - Neuroscience 2019Quote: ... For differentiation of fibroblasts to myofibroblasts 5ng/ml of TGF-β1 (7666-MB, R&D Systems) was used ...
-
bioRxiv - Bioengineering 2020Quote: ... recombinant basic fibroblast growth factor (10 ng/ml; Cat#233-GMP-025, R&D Systems, USA) and recombinant epidermal growth factor (10 ng/ml ...
-
bioRxiv - Physiology 2021Quote: ... 1% P/S antibiotics and 10 ng/ml basic fibroblast growth factor (bFGF) (R&D Systems). Human MPCs were trypsinized and incubated 30 min with biotinylated anti-human PDGFRα (BAF322 R&D Systems ...
-
bioRxiv - Neuroscience 2020Quote: ... cells were fluorescent activated cell (FACS)-sorted for human alkaline phosphatase (R&D systems, Minneapolis, MN, USA, Cat N° MAB1448) and expanded further in T75 flasks (Sigma ...
-
bioRxiv - Cell Biology 2022Quote: Cells were characterised using hPSC imaging kit (Human Pluripotent Stem Cell Marker Antibody Panel kit, SC008, R&D system, UK) with analysis performed on a flow cytometer (Beckman Coulter Cytomics FC 500) ...
-
bioRxiv - Immunology 2020Quote: ... isolated NK cells were cultured in 1000 IU/mL human IL-2 (R&D Systems) for 24 hours ...
-
bioRxiv - Microbiology 2021Quote: ... Cells were incubated in SFD medium supplemented with 100ng/ml human Noggin (R&D Systems) and 10μM SB431542 for 24 hours followed by switching to SFD media supplemented with 10 μM SB431542 and 1 μM IWP2 (R&D Systems ...
-
bioRxiv - Cancer Biology 2022Quote: ... Cells were treated with 5 ng/mL recombinant human TGFβ1 (R&D Systems, 240-B) prepared according to the manufacture’s specifications ...
-
bioRxiv - Bioengineering 2023Quote: ... as well as the Human Mesenchymal Stem Cells Multi-Color Flow Kit (R&D Systems) including antibodies for positive markers CD44 ...
-
bioRxiv - Microbiology 2023Quote: ... cells were treated with 25 ng/ml human IL-17 recombinant protein (R&D Systems). Vehicle control or 25 ng/ml human TNF-α recombinant protein were used as controls ...
-
bioRxiv - Immunology 2023Quote: ... recombinant human PD-L1 human IgG1 Fc chimera protein (R&D Systems), or mouse IgG1 isotype antibodies (R&D Systems ...
-
bioRxiv - Bioengineering 2023Quote: ... human fibronectin and human recombinant BMP-2 (R&D systems, Biotechne, UK); recombinant human BMP-2 (Infuse/InductOS® Bone graft kit ...
-
bioRxiv - Cell Biology 2024Quote: ... and 125 ng/mL Fibroblast growth factor (FGF) -8b (423-F8-025/CF; R&D Systems Inc) to DPSC-BM as previously reported [35] ...
-
bioRxiv - Immunology 2021Quote: ... TF-I cells medium contained 2 ng/ml of recombinant human GM-CSF (R&D Systems). Cells have been cultured for no longer than 4 weeks after thawing and were regularly tested for Mycoplasma contamination using PCR technique and were confirmed to be negative.